InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Friday, 05/03/2019 12:00:45 PM

Friday, May 03, 2019 12:00:45 PM

Post# of 1106
News: $IMGN ImmunoGen Reports Recent Progress and First Quarter 2019 Financial Results

Encouraging Efficacy Signal Observed in Pre-Specified Subset of Patients in Phase 3 FORWARD I Study; Company to Meet with Regulators this Quarter to Discuss Potential Path Forward for Mirvetuximab Soravtansine Monotherapy FORWARD II Trial with Mirvetuximab Combinations Continues to Enr...

In case you are interested https://marketwirenews.com/news-releases/immunogen-reports-recent-progress-and-first-quarter-2019-financial-results-8108678.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IMGN News